NDC codes

414365 NDC codes with hospital pricing data in the network.

• NDC 00407-1413-59 — Omnipaque 300 contrast injectionAI (463 hospitals, 297,249–301,326 samples)
• NDC 00270-5164-15 — MultiHance contrast agent injectionAI (518 hospitals, 266,758–273,976 samples)
• NDC 63323-0269-10 — Propofol 10 mg/mL injectable emulsion, 10 mL vialAI (359 hospitals, 268,463–273,467 samples)
• NDC 63323-0506-01 — Dexamethasone sodium phosphate 10 mg/mL injectionAI (1188 hospitals, 247,781–272,288 samples)
• NDC 00990-7922-02 — Dextrose 5% intravenous solutionAI (348 hospitals, 269,721–269,811 samples)
• NDC 00944-2700-05 — Gammagard 10 g/100 mL intravenous solutionAI (833 hospitals, 267,087–267,411 samples)
• NDC 00338-0709-48 — Potassium chloride IV solutionAI (926 hospitals, 263,983–266,512 samples)
• NDC 00002-8222-59 — Lispro insulin for pump infusion, 100 units per mLAI (127 hospitals, 259,576–259,792 samples)
• NDC 00407-1413-10 — Iohexol 300 contrast injectionAI (518 hospitals, 251,621–256,193 samples)
• NDC 70756-0621-25 — Phenylephrine injection (intravenous), 10 mg/mLAI (179 hospitals, 250,621–251,179 samples)
• NDC 63323-0751-13 — Phenylephrine injection, 100 mcg/mL IVAI (148 hospitals, 250,548–250,755 samples)
• NDC 63323-0751-03 — PHENYLEPHRINE 10 MG/ML SOLUTIONAI (133 hospitals, 250,080–250,422 samples)
• NDC 00990-7922-03 — Dextrose 5% intravenous solutionAI (323 hospitals, 246,163–246,325 samples)
• NDC 00264-9872-10 — Heparin in saline IV solutionAI (501 hospitals, 228,006–232,983 samples)
• NDC 00270-1316-37 — Isovue-370 iodinated contrast injectionAI (369 hospitals, 225,916–231,397 samples)
• NDC 00270-5164-12 — Gadobenate dimeglumine contrast injectionAI (327 hospitals, 228,326–229,478 samples)
• NDC 68982-0623-03 — Albumin 5% intravenous solutionAI (351 hospitals, 225,385–225,718 samples)
• NDC 50419-0320-05 — Eovist contrast agent injectionAI (832 hospitals, 219,768–223,530 samples)
• NDC 00990-7923-23 — Dextrose 5% intravenous solutionAI (234 hospitals, 223,004–223,157 samples)
• NDC 00270-1315-35 — Isovue-300 contrast injection solutionAI (618 hospitals, 210,594–220,341 samples)
• NDC 00338-0017-48 — Dextrose 5% intravenous solutionAI (586 hospitals, 216,978–218,364 samples)
• NDC 00990-7923-13 — Dextrose 5% intravenous solutionAI (240 hospitals, 211,162–211,477 samples)
• NDC 63323-0516-10 — Dexamethasone sodium phosphate injection 100 mg/10 mLAI (543 hospitals, 207,109–211,402 samples)
• NDC 00069-0209-01 — Propofol intravenous emulsion 200 mg/20 mLAI (357 hospitals, 205,980–208,176 samples)
• NDC 00264-7800-20 — Intravenous saline solution (0.9% sodium chloride)AI (738 hospitals, 194,414–208,022 samples)
• NDC 00990-7107-09 — Potassium chloride in dextrose and saline IV solutionAI (391 hospitals, 201,408–202,650 samples)
• NDC 63323-0269-50 — Propofol intravenous emulsion (Diprivan)AI (885 hospitals, 194,068–202,069 samples)
• NDC 00270-5164-14 — MultiHance contrast agent injectionAI (449 hospitals, 195,743–200,036 samples)
• NDC 00270-1316-45 — Isovue-370 iodinated contrast injectionAI (308 hospitals, 191,117–195,968 samples)
• NDC 00270-1315-30 — Isovue-300 contrast injection for imagingAI (562 hospitals, 181,784–189,875 samples)
• NDC 00990-7923-36 — Dextrose 5% in water IV solutionAI (199 hospitals, 185,214–185,304 samples)
• NDC 63323-0269-22 — Propofol intravenous emulsion 200 mg per 20 mLAI (408 hospitals, 180,187–184,939 samples)
• NDC 00270-1315-25 — Isovue-300 contrast dye for IV injectionAI (443 hospitals, 174,457–184,924 samples)
• NDC 00409-9094-22 — Fentanyl citrate injection, 100 mcg per 2 mLAI (976 hospitals, 147,067–183,292 samples)
• NDC 65250-0133-04 — Exparel (bupivacaine liposome) injectionAI (352 hospitals, 180,853–181,384 samples)
• NDC 00990-7923-37 — Dextrose 5% intravenous solutionAI (222 hospitals, 179,444–180,029 samples)
• NDC 63323-0464-01 — Bupivacaine 0.25% injection, preservative-freeAI (321 hospitals, 171,605–179,678 samples)
• NDC 00990-7983-61 — Sodium chloride 0.9% IV solutionAI (499 hospitals, 166,270–176,557 samples)
• NDC 17271-0720-05 — 5% dextrose in water intravenous solutionAI (81 hospitals, 174,524–174,641 samples)
• NDC 00990-7922-55 — Dextrose 5% intravenous solutionAI (125 hospitals, 174,244–174,325 samples)
• NDC 00990-7929-09 — Dextrose 5% in lactated Ringer's IV solutionAI (414 hospitals, 172,944–173,358 samples)
• NDC 00990-7922-53 — DEXTROSE INJ 5% (2 hospitals, 173,200 samples)
• NDC 60505-6130-05 — Ondansetron injection 4 mg/2 mLAI (870 hospitals, 151,148–169,085 samples)
• NDC 63323-0434-00 — Intravenous acetaminophen 1000 mgAI (551 hospitals, 160,372–167,473 samples)
• NDC 00338-0085-03 — Dextrose 5% and half-normal saline IV solutionAI (494 hospitals, 164,415–166,404 samples)
• NDC 63323-0411-25 — Midazolam injection, 5 mg per 5 mLAI (515 hospitals, 158,493–162,192 samples)
• NDC 00407-1413-65 — Iohexol 300 contrast injection for imagingAI (352 hospitals, 159,938–161,864 samples)
• NDC 00990-7115-09 — Potassium chloride in sodium chloride IV solutionAI (471 hospitals, 158,585–159,908 samples)
• NDC 00409-1159-01 — Bupivacaine 0.25% injection solutionAI (754 hospitals, 147,929–158,702 samples)
• NDC 72694-0515-01 — Calaspargase pegol injection, 5 mL vialAI (404 hospitals, 152,726–152,933 samples)